logo

ImmunoPrecise Antibodies Ltd (IPA) Stock: Navigating Market Highs and Lows in 52 Weeks

PNC Stock

The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. ImmunoPrecise Antibodies Ltd’s current trading price is -63.98% away from its 52-week high, while its distance from the 52-week low is 61.70%. The stock’s price range for this period has been between $0.94 and $4.22 The company’s shares, which are part of the Healthcare sector, had a trading volume of approximately 0.32 million for the day, a number notably lower than the average daily volume of 0.6 million over the last three months.

ImmunoPrecise Antibodies Ltd saw a rather unpredictable run in, in terms of market performance. The company’s stock reached its highest point at $4.22 on 05/12/23, while the lowest price for the same duration was marked at $0.94 on 12/06/23.

Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis

ImmunoPrecise Antibodies Ltd (IPA) has experienced a quarterly rise of 4.11% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 37.91M and boasts a workforce of 102 employees.

Analyzing Trading Volume and Moving Average Trends

Based on Barchart.com data, the company’s moving average over the 100-day period was 1.6047, with a change in price of -0.3900. Similarly, ImmunoPrecise Antibodies Ltd recorded 417,953 in trading volume during the last 100 days, posting a change of -20.42%.

Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis

The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for IPA stands at 0.29. Similarly, the long-term debt-to-equity ratio is also 0.25.

IPA Stock Stochastic Average

As of today, ImmunoPrecise Antibodies Ltd’s raw stochastic average for the last 50 days stands at 14.96%. This is a decline compared to the raw stochastic average of the previous 20 days, which was noted at 15.74%. Furthermore, the company’s Stochastic %K and %D values for the past 20 days were 17.29% and 17.29%, respectively.

IPA Stock Price Performance Analysis

A mixed performance in the stock price over the year has left investors with either an optimistic or pessimistic outlook, depending on their point of view. The index has shown a price loss of -11.11% this year. Over the last six months, there has been a stronger performance of -18.28%. The price of IPA leaped by -16.02% during the last 30 days period. For the last 5-days stocks have improved 8.57%.